ijms-logo

Journal Browser

Journal Browser

Traumatic Brain Injury/Chronic Traumatic Encephalopathy as Cause of Alzheimer’s Disease: Physics and Molecular Biology in the Genesis of Neurodegeneration?

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Neurobiology".

Deadline for manuscript submissions: 20 September 2024 | Viewed by 1579

Special Issue Editor


E-Mail Website
Guest Editor
Department of Pathology, University of Nicosia Medical School, Nicosia, Cyprus
Interests: neurooncology; neurodegenerative diseases; traumatic brain injury/chronic traumatic encephalopathy; demyelinating diseases; neurodevelopmental disorders; neuromuscular disorders
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Background

Neurodegenerative diseases encompass a group of nosological entities that manifest either as a decline in the cognitive capacity (e.g. Alzheimer’s Disease [AD], Fronto-Temporal Dementia [FTD], Lewy Body Dementia [LBD]) or as an altered motor function with variable but disordered movement patterns (e.g. Parkinson’s Disease [PD], Huntington’s Disease [HD], Multiple System Atrophy [MSA]) of the affected individuals. The etiological factor behind all these well recognised clinical presentations is the substantial degeneration of the neurons, whether these are located within the brain or the spinal cord. Several intra- (e.g. neurofibrillary tangles [NFTs], Lewy bodies) and extracellular deposits (e.g. senile [neuritic] plaques) have been described until now and they have been implicated in the damage of the neuronal cells. Furthermore, specific protein aggregates have been found as components of these abnormal structures. Thus, it has been revealed that neurofibrillary tangles contain hyperphosphorylated tau-protein, Lewy bodies comprise a-synuclein, while senile [neuritic] plaques are composed mainly by b-amyloid accumulates. Recently, scientific society has paid particular attention to conditions named traumatic brain injury (TBI) and chronic traumatic encephalopathy (CTE; the neurobehavioral profile after the occurrence of repeated TBIs), as these has been shown to be associated with some of the above described neurodegenerative diseases (e.g. Alzheimer’s disease, Parkinson’s disease). In particular, common features described both in TBI/CTE and Alzheimer’s disease include dementia as well as morphological changes, both at the macroscopic level with brain atrophy and at the microscopic level with the presence of phosphorylated tau inclusions and senile [neuritic] plaques.

Summary

Although a lot of progress has been attained during the last few years in the field of neurodegenerative diseases, the actual pathogenetic mechanism that leads to their development has not been fully elucidated. In this context, several studies have also tried to understand whether there is a connection between Traumatic Brain Injury (TBI)/Chronic Traumatic Encephalopathy (CTE) and Alzheimer’s disease, considering their similarities in the clinical manifestations and histopathological characteristics, but without the expected outcome. Thus, the question that has to be answered still remains; could physical stress, in the form of a brain trauma (TBI/CTE), be the reason for the subsequent biological changes taking place inside the neurons, leading substantially to their damage and death (manifested as Alzheimer’s disease)? In other words, is it possible to establish a "cause-effect" relationship, between TBI/CTE (cause) and Alzheimer’s disease (effect)? “Hic Rhodus, hic salta”.

Prof. Dr. Dimitrios Kanakis
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • traumatic brain injury (TBI)
  • chronic traumatic encephalopathy (CTE)
  • head impacts
  • Alzheimer's disease (AD)
  • neurodegeneration

Published Papers (3 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Review

18 pages, 3207 KiB  
Article
Early Blood–Brain Barrier Impairment as a Pathological Hallmark in a Novel Model of Closed-Head Concussive Brain Injury (CBI) in Mice
by Stefan J. Blaschke, Nora Rautenberg, Heike Endepols, Aileen Jendro, Jens Konrad, Susan Vlachakis, Dirk Wiedermann, Michael Schroeter, Bernd Hoffmann, Rudolf Merkel, Niklas Marklund, Gereon R. Fink and Maria A. Rueger
Int. J. Mol. Sci. 2024, 25(9), 4837; https://doi.org/10.3390/ijms25094837 (registering DOI) - 29 Apr 2024
Viewed by 111
Abstract
Concussion, caused by a rotational acceleration/deceleration injury mild enough to avoid structural brain damage, is insufficiently captured in recent preclinical models, hampering the relation of pathophysiological findings on the cellular level to functional and behavioral deficits. We here describe a novel model of [...] Read more.
Concussion, caused by a rotational acceleration/deceleration injury mild enough to avoid structural brain damage, is insufficiently captured in recent preclinical models, hampering the relation of pathophysiological findings on the cellular level to functional and behavioral deficits. We here describe a novel model of unrestrained, single vs. repetitive concussive brain injury (CBI) in male C56Bl/6j mice. Longitudinal behavioral assessments were conducted for up to seven days afterward, alongside the evaluation of structural cerebral integrity by in vivo magnetic resonance imaging (MRI, 9.4 T), and validated ex vivo by histology. Blood–brain barrier (BBB) integrity was analyzed by means of fluorescent dextran- as well as immunoglobulin G (IgG) extravasation, and neuroinflammatory processes were characterized both in vivo by positron emission tomography (PET) using [18F]DPA-714 and ex vivo using immunohistochemistry. While a single CBI resulted in a defined, subacute neuropsychiatric phenotype, longitudinal cognitive testing revealed a marked decrease in spatial cognition, most pronounced in mice subjected to CBI at high frequency (every 48 h). Functional deficits were correlated to a parallel disruption of the BBB, (R2 = 0.29, p < 0.01), even detectable by a significant increase in hippocampal uptake of [18F]DPA-714, which was not due to activation of microglia, as confirmed immunohistochemically. Featuring a mild but widespread disruption of the BBB without evidence of macroscopic damage, this model induces a characteristic neuro-psychiatric phenotype that correlates to the degree of BBB disruption. Based on these findings, the BBB may function as both a biomarker of CBI severity and as a potential treatment target to improve recovery from concussion. Full article
Show Figures

Figure 1

Review

Jump to: Research

19 pages, 1290 KiB  
Review
Chronic Traumatic Encephalopathy as the Course of Alzheimer’s Disease
by Magdalena Pszczołowska, Kamil Walczak, Weronika Miśków, Katarzyna Antosz, Joanna Batko, Donata Kurpas and Jerzy Leszek
Int. J. Mol. Sci. 2024, 25(9), 4639; https://doi.org/10.3390/ijms25094639 - 24 Apr 2024
Viewed by 434
Abstract
This editorial investigates chronic traumatic encephalopathy (CTE) as a course of Alzheimer’s disease (AD). CTE is a debilitating neurodegenerative disease that is the result of repeated mild traumatic brain injury (TBI). Many epidemiological studies show that experiencing a TBI in early or middle [...] Read more.
This editorial investigates chronic traumatic encephalopathy (CTE) as a course of Alzheimer’s disease (AD). CTE is a debilitating neurodegenerative disease that is the result of repeated mild traumatic brain injury (TBI). Many epidemiological studies show that experiencing a TBI in early or middle life is associated with an increased risk of dementia later in life. Chronic traumatic encephalopathy (CTE) and Alzheimer’s disease (AD) present a series of similar neuropathological features that were investigated in this work like recombinant tau into filaments or the accumulation and aggregation of Aβ protein. However, these two conditions differ from each other in brain–blood barrier damage. The purpose of this review was to evaluate information about CTE and AD from various articles, focusing especially on new therapeutic possibilities for the improvement in cognitive skills. Full article
Show Figures

Figure 1

24 pages, 1828 KiB  
Review
The Role of Oxygen Homeostasis and the HIF-1 Factor in the Development of Neurodegeneration
by Elena V. Mitroshina and Maria V. Vedunova
Int. J. Mol. Sci. 2024, 25(9), 4581; https://doi.org/10.3390/ijms25094581 - 23 Apr 2024
Viewed by 294
Abstract
Understanding the molecular underpinnings of neurodegeneration processes is a pressing challenge for medicine and neurobiology. Alzheimer’s disease (AD) and Parkinson’s disease (PD) represent the most prevalent forms of neurodegeneration. To date, a substantial body of experimental evidence has strongly implicated hypoxia in the [...] Read more.
Understanding the molecular underpinnings of neurodegeneration processes is a pressing challenge for medicine and neurobiology. Alzheimer’s disease (AD) and Parkinson’s disease (PD) represent the most prevalent forms of neurodegeneration. To date, a substantial body of experimental evidence has strongly implicated hypoxia in the pathogenesis of numerous neurological disorders, including AD, PD, and other age-related neurodegenerative conditions. Hypoxia-inducible factor (HIF) is a transcription factor that triggers a cell survival program in conditions of oxygen deprivation. The involvement of HIF-1α in neurodegenerative processes presents a complex and sometimes contradictory picture. This review aims to elucidate the current understanding of the interplay between hypoxia and the development of AD and PD, assess the involvement of HIF-1 in their pathogenesis, and summarize promising therapeutic approaches centered on modulating the activity of the HIF-1 complex. Full article
Show Figures

Figure 1

Back to TopTop